Last updated on September 2020

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis


Brief description of study

The main objectives of this trial are to evaluate the long term efficacy and safety of different doses of BI 655064 versus placebo as add-on therapy to Standard of Care (SOC) during maintenance therapy for lupus nephritis.

Detailed Study Description

Initially planned participating countries:

Argentina, Australia, Canada, Colombia, Czech Republic, France, Germany, Greece, Hong Kong, Italy, Japan, Republic of Korea, Malaysia, Mexico, Philippines, Poland, Portugal, Serbia, Spain, Taiwan, Thailand, United Kingdom, United States

Clinical Study Identifier: NCT03385564

Find a site near you

Start Over

Guy's Hospital

London, United Kingdom
  Connect »

Northwell Health

Great Neck, NY United States
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Addenbrooke's Hospital

Cambridge, United Kingdom
  Connect »

Ajou University Hospital

Suwon, Korea, Republic of
  Connect »

Mary Mediatrix Medical Center

Lipa City, Batangas, Philippines
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.